Publications by authors named "Uday Bose"

Claim this Profile
A
A cost-effectiveness analysis of docetaxel in the second-line treatment of non-small cell lung cancer.
Jeremy Holmes, David Dunlop, Lindsay Hemmett, Peter Sharplin, Uday Bose

Pharmacoeconomicsยท September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis